<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24098754</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>9</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro.</ArticleTitle><Pagination><StartPage>e76007</StartPage><MedlinePgn>e76007</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e76007</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0076007</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is an etiology for a number of diseases in humans. Traditional Chinese herbs have been reported to be effective for treating EV71 infection. However, there is no report about the antiviral effects of CHA against EV71. In this study, plaque reduction assay demonstrated that the inhibitory concentration 50% (IC50) of CHA on EV71 replication is 6.3 &#xb5;g/ml. When both CHA (20 &#xb5;g/ml) and EV71 were added, or added post-infection at different time points, CHA was able to effectively inhibit EV71 replication between 0 and 10 h. In addition, CHA inhibited EV71 2A transcription and translation in EV71-infected RD cells, but did not affect VP1, 3C, and 3D expression. Furthermore, CHA inhibited secretions of IL-6, TNF-&#x3b1;, IFN-&#x3b3; and MCP-1 in EV71-infected RD cells. Altogether, these results revealed that CHA may have antiviral properties for treating EV71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Third Affiliated Hospital of Suzhou University, Changzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xueling</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Hongjun</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Qingbo</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Mei</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Yun</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuyue</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C111835">CCL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>318ADP12RI</RegistryNumber><NameOfSubstance UI="D002726">Chlorogenic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002726" MajorTopicYN="N">Chlorogenic Acid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050296" MajorTopicYN="N">Microbial Viability</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24098754</ArticleId><ArticleId IdType="pmc">PMC3786884</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0076007</ArticleId><ArticleId IdType="pii">PONE-D-13-23744</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Wong SS, Yip CC, Lau SK, Yuen KY (2010) Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect
138: 1071-1089. doi:10.1017/S0950268809991555. PubMed: 20056019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268809991555</ArticleId><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>
Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P
et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis
10: 778-790. doi:10.1016/S1473-3099(10)70194-8. PubMed: 20961813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hsu CH, Lu CY, Shao PL, Lee PI, Kao CL
et al. (2011) Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect
44: 265-273. doi:10.1016/j.jmii.2011.01.029. PubMed: 21524954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2011.01.029</ArticleId><ArticleId IdType="pubmed">21524954</ArticleId></ArticleIdList></Reference><Reference><Citation>
Irani DN (2008) Aseptic meningitis and viral myelitis. Neurol Clin
26: 635-655. doi:10.1016/j.ncl.2008.03.003. PubMed: 18657719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2008.03.003</ArticleId><ArticleId IdType="pmc">PMC2728900</ArticleId><ArticleId IdType="pubmed">18657719</ArticleId></ArticleIdList></Reference><Reference><Citation>
Lei X, Liu X, Ma Y, Sun Z, Yang Y
et al. (2010) The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol
84: 8051-8061. doi:10.1128/JVI.02491-09. PubMed: 20519382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hung H-C, Chen T-C, Fang M-Y, Yen K-J, Shih S-R
et al. (2010) Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chem
65: 676-683. doi:10.1093/jac/dkp502. PubMed: 20089540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp502</ArticleId><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>
Akahata W, Yang Z-Y, Andersen H, Sun S, Holdaway HA
et al. (2010) A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med
16: 334-338. doi:10.1038/nm.2105. PubMed: 20111039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2105</ArticleId><ArticleId IdType="pmc">PMC2834826</ArticleId><ArticleId IdType="pubmed">20111039</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kleymann G (2003) Novel agents and strategies to treat herpes simplex virus infections. Expert Opin Investig Drugs
12: 165-183. doi:10.1517/13543784.12.2.165. PubMed: 12556212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543784.12.2.165</ArticleId><ArticleId IdType="pubmed">12556212</ArticleId></ArticleIdList></Reference><Reference><Citation>
Peppa D, Micco L, Javaid A, Kennedy PT, Schurich A
et al. (2010) Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLOS Pathog
6:e1001227 PubMed: 21187913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3003000</ArticleId><ArticleId IdType="pubmed">21187913</ArticleId></ArticleIdList></Reference><Reference><Citation>
Olivier AK, Gallup JM, Geelen AV
Ackermann MR (2011) Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res
37: 131-143. doi:10.3109/01902148.2010.484518. PubMed: 21309731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01902148.2010.484518</ArticleId><ArticleId IdType="pmc">PMC3169812</ArticleId><ArticleId IdType="pubmed">21309731</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wu KX, Ng MM-L, Chu JJ (2010) Developments towards antiviral therapies against enterovirus 71. Drug Discov Today
15: 1041-1051. doi:10.1016/j.drudis.2010.10.008. PubMed: 20974282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2010.10.008</ArticleId><ArticleId IdType="pmc">PMC7108380</ArticleId><ArticleId IdType="pubmed">20974282</ArticleId></ArticleIdList></Reference><Reference><Citation>
Qi W, Zhao T, Yang W-W, Wang G-H, Yu H
et al. (2011) Comparative pharmacokinetics of chlorogenic acid after oral administration in rats. J Pharm Anal
1: 270-274. doi:10.1016/j.jpha.2011.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpha.2011.09.006</ArticleId><ArticleId IdType="pmc">PMC5760807</ArticleId><ArticleId IdType="pubmed">29403709</ArticleId></ArticleIdList></Reference><Reference><Citation>
McDougall B, King PJ, Wu BW, Hostomsky Z, Reinecke MG
et al. (1998) Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob Agents Chemother
42: 140-146. PubMed: 9449274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC105469</ArticleId><ArticleId IdType="pubmed">9449274</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chiang LC, Chiang W, Chang MY, Ng LT, Lin CC (2002) Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res
55: 53-62. doi:10.1016/S0166-3542(02)00007-4. PubMed: 12076751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-3542(02)00007-4</ArticleId><ArticleId IdType="pubmed">12076751</ArticleId></ArticleIdList></Reference><Reference><Citation>
L&#xfc;ckemeyer DD, M&#xfc;ller VD, Moritz MI, Stoco PH, Schenkel EP
et al. (2012) Effects of Ilex paraguariensis A. St. Hil. (yerba mate) on herpes simplex virus types 1 and 2 replication. Phytother Res
26: 535-540. doi:10.1002/ptr.3590. PubMed: 21915933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.3590</ArticleId><ArticleId IdType="pubmed">21915933</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ikeda K, Tsujimoto K, Uozaki M, Nishide M, Suzuki Y
et al. (2011) Inhibition of multiplication of herpes simplex virus by caffeic acid. Int J Mol Med
28: 595-598. PubMed: 21725588.</Citation><ArticleIdList><ArticleId IdType="pubmed">21725588</ArticleId></ArticleIdList></Reference><Reference><Citation>
De Francesco R, Carf&#xed; A (2007) Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Adv Drug Deliv Rev
59: 1242-1262. doi:10.1016/j.addr.2007.04.016. PubMed: 17869377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2007.04.016</ArticleId><ArticleId IdType="pubmed">17869377</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sampath A, Padmanabhan R (2009) Molecular targets for flavivirus drug discovery. Antiviral Res
81: 6-15. doi:10.1016/j.antiviral.2008.08.004. PubMed: 18796313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2008.08.004</ArticleId><ArticleId IdType="pmc">PMC2647018</ArticleId><ArticleId IdType="pubmed">18796313</ArticleId></ArticleIdList></Reference><Reference><Citation>
Shang L, Xu M, Yin Z (2013) Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res
97: 183-194. doi:10.1016/j.antiviral.2012.12.005. PubMed: 23261847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.005</ArticleId><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>
Brown BA, Oberste MS, Alexander JP Jr., Kennett ML, Pallansch MA (1999) Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol
73: 9969-9975. PubMed: 10559310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hsu B-M, Chen C-H, Wan M-T (2007) Genetic diversity of epidemic enterovirus 71 strains recovered from clinical and environmental samples in Taiwan. Virus Res
126: 69-75. doi:10.1016/j.virusres.2007.01.018. PubMed: 17363101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2007.01.018</ArticleId><ArticleId IdType="pubmed">17363101</ArticleId></ArticleIdList></Reference><Reference><Citation>
Lin T-Y, Liu Y-C, Jheng J-R, Tsai H-P, Jan J-T
et al. (2009) Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med
37: 143-158. doi:10.1142/S0192415X09006734. PubMed: 19222118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X09006734</ArticleId><ArticleId IdType="pubmed">19222118</ArticleId></ArticleIdList></Reference><Reference><Citation>
Lin C-W, Wu C-F, Hsiao N-W, Chang C-Y, Li S-W
et al. (2008) Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents
32: 355&#x2013;359. doi:10.1016/j.ijantimicag.2008.04.018. PubMed: 18701259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2008.04.018</ArticleId><ArticleId IdType="pmc">PMC7126984</ArticleId><ArticleId IdType="pubmed">18701259</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wu B-W, Pan T-L, Leu Y-L, Chang Y-K, Tai P-J
et al. (2007) Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71. Am J Chin Med
35: 153-168. doi:10.1142/S0192415X07004709. PubMed: 17265559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X07004709</ArticleId><ArticleId IdType="pubmed">17265559</ArticleId></ArticleIdList></Reference><Reference><Citation>
Superti F, Ammendolia MG, Marchetti M (2008) New advances in anti-HSV chemotherapy. Curr Med Chem
15: 900-911. doi:10.2174/092986708783955419. PubMed: 18473797.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986708783955419</ArticleId><ArticleId IdType="pubmed">18473797</ArticleId></ArticleIdList></Reference><Reference><Citation>
Khan MT, Ather A, Thompson KD, Gambari R (2005) Extracts and molecules from medicinal plants against herpes simplex viruses. Antiviral Res
67: 107-119. doi:10.1016/j.antiviral.2005.05.002. PubMed: 16040137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.05.002</ArticleId><ArticleId IdType="pubmed">16040137</ArticleId></ArticleIdList></Reference><Reference><Citation>
Tamura H, Akioka T, Ueno K, Chujyo T, Okazaki K
et al. (2006) Anti-human immunodeficiency virus activity of 3,4,5-tricaffeoylquinic acid in cultured cells of lettuce leaves. Mol Nutr Food Res
50: 396-400. doi:10.1002/mnfr.200500216. PubMed: 16598806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200500216</ArticleId><ArticleId IdType="pubmed">16598806</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wang G-F, Shi L-P, Ren Y-D, Liu Q-F, Liu H-F
et al. (2009) Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antiviral Res
83: 186-190. doi:10.1016/j.antiviral.2009.05.002. PubMed: 19463857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.05.002</ArticleId><ArticleId IdType="pubmed">19463857</ArticleId></ArticleIdList></Reference><Reference><Citation>
Rivas-Aravena A, Vallejos-Vidal E, Cortez-San Martin M, Reyes-Lopez F, Tello M, et al. (2011) Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection. J Virol
85: 8037-8045. doi:10.1128/JVI.00533-11. PubMed: 21653663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00533-11</ArticleId><ArticleId IdType="pmc">PMC3147947</ArticleId><ArticleId IdType="pubmed">21653663</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bougie I, Bisaillon M (2004) The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J Biol Chem
279: 22124-22130. doi:10.1074/jbc.M400908200. PubMed: 15037606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M400908200</ArticleId><ArticleId IdType="pubmed">15037606</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chen X, Zhang Q, Li J, Cao W, Zhang JX
et al. (2010) Analysis of recombination and natural selection in human enterovirus 71. Virology
398: 251-261. doi:10.1016/j.virol.2009.12.007. PubMed: 20060995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.12.007</ArticleId><ArticleId IdType="pubmed">20060995</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kuo R-L, Kung S-H, Hsu Y-Y, Liu W-T (2002) Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol
83: 1367-1376. PubMed: 12029152.</Citation><ArticleIdList><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>
Goldstaub D, Gradi A, Bercovitch Z, Grosmann Z, Nophar Y
et al. (2000) Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol
20: 1271-1277. doi:10.1128/MCB.20.4.1271-1277.2000. PubMed: 10648613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.4.1271-1277.2000</ArticleId><ArticleId IdType="pmc">PMC85262</ArticleId><ArticleId IdType="pubmed">10648613</ArticleId></ArticleIdList></Reference><Reference><Citation>
Morrison JM, Racaniello VR (2009) Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J Virol
83: 4412-4422. doi:10.1128/JVI.02177-08. PubMed: 19211759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02177-08</ArticleId><ArticleId IdType="pmc">PMC2668472</ArticleId><ArticleId IdType="pubmed">19211759</ArticleId></ArticleIdList></Reference><Reference><Citation>
Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM
et al. (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem
282: 2871-2879. PubMed: 17132626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693903</ArticleId><ArticleId IdType="pubmed">17132626</ArticleId></ArticleIdList></Reference><Reference><Citation>
Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y
et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-&#x3b2; and TNF-&#x3b1;, by human macrophages. J Immunol
160: 3513-3521. PubMed: 9531313.</Citation><ArticleIdList><ArticleId IdType="pubmed">9531313</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gong X, Zhou J, Zhu W, Liu N, Li J
et al. (2012) Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection. BMC Infect Dis
12: 224. doi:10.1186/1471-2334-12-224. PubMed: 22994237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-224</ArticleId><ArticleId IdType="pmc">PMC3519709</ArticleId><ArticleId IdType="pubmed">22994237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>